CK Life Sciences Intl (Holdings) Inc — SEC Form 4 filings

SEC reporting owner CIK 1297567. 3 Form 4 filings on record with FilingPulse; latest filed 2026-08-05.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2025-03-17 to 2026-08-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Dogwood Therapeutics, Inc. (DWTX)Director, 10% owner25
Transcode Therapeutics, Inc. (RNAZ)10% owner14

Form 4 filings — CK Life Sciences Intl (Holdings) Inc

FiledFormIssuerReported transactionsSource
2026-08-054Transcode Therapeutics, Inc. (RNAZ)
jointly with DEFJ, LLC
Conversion (C): 11,813,859 · Conversion (C): 2,020,582 · Conversion (C): 1,181.39 (derivative) @ $0 · Conversion (C): 202.06 (derivative) @ $0EDGAR
2025-11-254Dogwood Therapeutics, Inc. (DWTX)
jointly with Sealbond Ltd, Conjoint Inc.
Conversion (C): 21,610,950 · Conversion (C): 2,842,638 · Conversion (C): 2,161.09 (derivative) @ $0 · Conversion (C): 284.26 (derivative) @ $0EDGAR
2025-03-174Dogwood Therapeutics, Inc. (DWTX)Grant/award (A): 284.26 (derivative) @ $7.01EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1297567 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →